Who owns SILENCE THERAPEUTICS PLC?
- Ticker: SLN
- CUSIP Number: 82686q101
Tip: Access positions for across all investors
Analyze quarterly positions in Silence Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Silence Therapeutics stock
Who bought or sold SILENCE THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| TCG Crossover Management | 3.0M | $16M | 0% | Mar 2026 |
|
| Siren | 2.9M | $18M | 0% | Dec 2025 |
|
| Redmile Group | 2.2M | $11M | 0% | Mar 2026 |
|
| Nantahala Capital Management | 2.1M | $11M | 39% | Mar 2026 |
|
| Citadel Advisors | 1.2M | $6.6M | 381% | Mar 2026 |
|
| Millennium Management | 1.1M | $5.7M | 63% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.0M | $5.4M | 26% | Mar 2026 |
|
| Nextech Invest | 952k | $5.0M | 0% | Mar 2026 |
|
| Ikarian Capital | 866k | $1.7M | 0% | Mar 2026 |
|
| Polygon Management | 630k | $3.3M | 72% | Mar 2026 |
|
| 5AM Venture Management | 476k | $2.5M | 0% | Mar 2026 |
|
| Jones Hill Capital | 302k | $1.6M | 100% | Mar 2026 |
|
| SG Americas Securities | 287k | $1.5M | 12% | Mar 2026 |
|
| Lombard Odier Asset Management | 256k | $1.2M | -86% | Dec 2025 |
|
| UBS Group | 247k | $1.3M | 19% | Mar 2026 |
|
| Boothbay Fund Management | 209k | $1.1M | 0% | Mar 2026 |
|
| BlackRock | 205k | $1.1M | 180% | Mar 2026 |
|
| Bank Of Montreal | 203k | $1.1M | 100% | Mar 2026 |
|
| M28 Capital Management | 185k | $1.1M | 0% | Dec 2025 |
|
| ADAR1 Capital Management | 172k | $907k | 628% | Mar 2026 |
|
| Seven Fleet Capital Management | 157k | $826k | 6% | Mar 2026 |
|
| Marshall Wace | 156k | $947k | 87% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 148k | $778k | 1128% | Mar 2026 |
|
| Hsbc Holdings | 123k | $640k | -29% | Mar 2026 |
|
| Point72 Asset Management | 120k | $631k | 5% | Mar 2026 |
|
| Jane Street | 101k | $532k | 246% | Mar 2026 |
|
| Squarepoint Ops | 90k | $472k | 100% | Mar 2026 |
|
| Morgan Stanley | 66k | $345k | -80% | Mar 2026 |
|
| Quadrature Capital | 54k | $331k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 53k | $277k | 190% | Mar 2026 |
|
| Susquehanna International | 42k | $255k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 35k | $213k | 100% | Dec 2025 |
|
| Bank of America Corporation | 30k | $157k | 100% | Mar 2026 |
|
| Geode Capital Management | 30k | $156k | 0% | Mar 2026 |
|
| Raymond James Financial | 25k | $152k | 100% | Dec 2025 |
|
| Two Sigma Investments | 16k | $85k | -59% | Mar 2026 |
|
| Rhumbline Advisers | 14k | $73k | 7% | Mar 2026 |
|
| Hrt Financial | 12k | $63k | 100% | Mar 2026 |
|
| XTX Topco | 12k | $71k | 100% | Dec 2025 |
|
| Dynamic Technology Lab Private | 11k | $55k | 100% | Mar 2026 |
|
| GAMMA Investing | 9.4k | $49k | -7% | Mar 2026 |
|
| China Universal Asset Management | 8.3k | $44k | -39% | Mar 2026 |
|
| Barclays | 5.1k | $31k | -29% | Dec 2025 |
|
| Acadian Asset Management | 4.8k | $25k | 100% | Mar 2026 |
|
| Simplex Trading | 4.0k | $24k | 513% | Dec 2025 |
|
| Jones Financial Companies, L.L | 2.5k | $15k | 0% | Dec 2025 |
|
| Mirae Asset Global Investments | 2.5k | $13k | 7% | Mar 2026 |
|
| Tower Research Capital | 2.4k | $15k | 0% | Dec 2025 |
|
| Citigroup | 1.8k | $9.7k | 100% | Mar 2026 |
|
| Parallel Advisors | 1.3k | $6.9k | 0% | Mar 2026 |
|
| Gf Fund Management | 1.0k | $5.5k | 14% | Mar 2026 |
|
| Global Retirement Partners | 1.0k | $6.1k | 100% | Dec 2025 |
|
| Steward Partners Investment Advisory | 100.00 | $527.000000 | 0% | Mar 2026 |
|
| Rockefeller Capital Management | 45.00 | $237.001500 | 0% | Mar 2026 |
|
| SBI Securities | 28.00 | $147.999600 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 16.00 | $0 | -99% | Mar 2026 |
|
| SageView Advisory Group | 11.00 | $66.999900 | 100% | Dec 2025 |
|
| Caitong International Asset Management | 3.00 | $15.999900 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 3.00 | $18.000000 | -100% | Dec 2025 |
|
Who sold out of Silence Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vivo Capital | Dec 2025 | 1.1M | $6.7M |
| Opaleye Management | Dec 2025 | 79k | $480k |
| Virtus Investment Advisers | Sep 2025 | 20k | $106k |
| Two Sigma Advisers | Dec 2025 | 16k | $97k |
| EHP Funds | Sep 2025 | 11k | $55k |
| Jpmorgan Chase & Co | Sep 2025 | 7.8k | $40k |